← Open Payments lookup

DAVID HAGEMANN: Open Payments

NPI 1881675619 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,345 in 118 payments from 20 companies in 2025. Trend: 2023 $2,486 · 2024 $2,499 · 2025 $2,345

Food & beverage: $2,345
CompanyPaymentsAmount
GENZYME CORPORATION11$326
ABBVIE INC.17$262
Incyte Corporation10$232
LEO Pharma Inc.12$213
E.R. Squibb & Sons, L.L.C.11$188
Lilly USA, LLC9$161
Galderma Laboratories, L.P.10$159
Regeneron Healthcare Solutions, Inc.6$145
SUN PHARMACEUTICAL INDUSTRIES INC.8$139
Novartis Pharmaceuticals Corporation3$75

Products named: DUPIXENT, OPZELURA, Sotyktu, ADBRY, NEMLUVIO, TALTZ, SKYRIZI, RINVOQ.

Industry payments across CA — which companies pay providers there.